For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...
The FDA Fast Track and Accelerated Approval pathways have major implications for the wider healthcare landscape beyond drug ...
Discover how to navigate CMC processes effectively in drug development. Learn from industry leaders and ensure your project’s ...
Milestone Pharmaceuticals (MIST) has released an update. Milestone Pharmaceuticals is gearing up for the potential FDA approval of its CARDAMYST nasal spray for PSVT, with a decision expected by March ...
Joint efforts promise innovative drug solutions and enhanced offerings while enabling comprehensive development of active ...
The intersection of sports marketing and the pharmaceutical industry offers a dynamic space where brands can leverage ...
Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...
Transpire Bio expands headquarters in Weston, adding 6,600 square feet. New executives join, including Stuart Loesch and Todd ...
However, the biotech and pharmaceutical companies that develop these therapies do so at great expense. High drug development ...
It is great to leverage MSD’s future-focused and cutting-edge global network, boasting some of the most advanced pharma research, development and manufacturing facilities in the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback